• Home
  • Victims
    • Vaccine Victims Memorial
    • Gardasil & Silgard
      • G / S Australasia
        • G / S Australia
        • G / S New Zealand
      • G / S Europe
        • G / S Czech Republic
        • G / S Denmark
        • G / S France
        • G / S Germany
        • G / S Ireland
        • G / S Italy
        • G / S Norway
        • G / S Scotland
        • G / S Spain
        • G / S United Kingdom
      • G / S N. America
        • G / S Canada
        • G / S Mexico
        • G / S United States
      • G / S S. America
        • G / S Brazil
        • G/S Colombia
    • Cervarix
      • Cervarix Asia
        • Cervarix India
        • Cervarix Philippines
      • Cervarix Europe
        • Cervarix Czech
        • Cervarix Netherlands
        • Cervarix Scotland
        • Cervarix Slovakia
        • Cervarix Spain
        • Cervarix UK
      • Cervarix N. America
        • Cervarix Mexico
  • Resources
    • HPV Testing Resources
      • Pre-HPV Vaccination
      • Post-HPV Vaccination
    • Medical Professionals
    • Vaccine Injury Attorneys
    • Political Action Groups
    • Vaccine Groups
    • Vaccine Victims Hotline
  • SANE Vax Press Releases
  • Videos
    • Vaccine Safety Videos
    • Vaccine Victim Videos
    • Pharma Videos
  • About
    • About Us
    • Who We Are
    • Press Releases
    • SANE Vax in the News
    • Contact Us

SaneVax, Inc.

The First International HPV Vaccine Information Clearinghouse

  • NEWS
    • Government Agencies
      • African
      • Asian
      • Australasian
      • European
      • North American
      • South American
      • United Nations
      • WHO
    • Pharmaceutical Companies
      • CSL Biotherapies
      • GlaxoSmithKline
      • Inovio Pharmaceuticals
      • Liquidia Technologies
      • Merck & Co.
      • Novartis
      • Pfizer
      • Qiagen
      • Sanofi Aventis
      • Sanofi Pasteur MSD spmsd
      • Wyeth Laboratories
    • Science & Medicine
      • Cancer
      • Clinical Trials
      • Environmental Health
      • Heavy Metal Toxicity
      • HPV Science
      • Influenza
      • Meningitis
      • Pertussis
      • Pharmaceuticals
      • Rotavirus
      • STD’s
      • Vaccine Science
      • Women’s Health
    • Vaccine Adverse Events
    • Vaccine Injury Reporting
      • VAERS
      • VAMPSS
    • Vaccine Litigation
    • Vaccine Marketing
    • Vaccine Politics/People
    • Vaccine Victims
      • Cervarix Injuries
      • DTP/DTaP Injuries
      • Fluvax Injuries
      • Fluzone Injuries
      • Gardasil / Silgard Injuries
      • Menomune Injuries
      • MMR Injuries
      • Polio Vaccine Injuries
      • Synflorix Injuries
      • Yellow Fever Vaccine
    • Vaccines
      • Anthrax
      • Breast Cancer
      • Chicken Pox
      • Cholera
      • Combination Vaccines
      • Diphtheria
      • Hepatitis B
      • HPV
      • Influenza Vaccines
      • Malaria
      • Measles
      • Meningitis Vaccines
      • MRSA
      • Mumps
      • Norovirus
      • Pertussis Vaccines
      • Pneumococcal Disease
      • Polio
      • Rotavirus Vaccines
      • Shingles
      • Smallpox
      • TB
      • Tetanus
      • Typhoid
      • Yellow Fever Vaccine
    • Vaccines and the Media
  • WORLD NEWS
    • Africa
    • Asia
    • Australasia
    • Europe
    • North America
    • South America
  • RESEARCH
    • Cancer Research
    • Cervarix Vaccine
    • Gardasil/Silgard Vaccine
    • Human Pap. Research
    • Immunization Practices
    • Neurology
    • Vaccine Adjuvants
    • Vac. Ingredient Research
    • Vaccine Injuries
    • Vaccine Preservatives
    • Vaccine Related Research
    • Vaccine Safety
  • CITIZENS SPEAK
    • Cervical Cancer Debate
    • HPV Vax
      • Australian Concerns
      • Canadian Concerns
      • Irish Concerns
      • Spain Concerns
      • UK Concerns
      • United States Concerns
You are here: Home / NEWS . . . . . . . . / Government Agencies / North American / The United States / HHS / Federal officials launch new vaccine strategy, get flu immunization update

Federal officials launch new vaccine strategy, get flu immunization update

February 18, 2011 By Norma Leave a Comment

By Lisa Schnirring, Staff Writer

(CIDRAP News) – A federal vaccine advisory group meeting in Washington, DC, today unveiled a new national vaccination strategy for the next decade and reviewed the latest information on influenza vaccination in the first year of a new universal recommendation.

The first day of the 2-day National Vaccine Advisory Committee (NVAC), which advises the US Department of Health and Human Services (HHS), mainly focused on the release of the new vaccine plan and influenza vaccine updates. The meeting was broadcast live in HHS Web video and audio links.

Committee members heard from several groups involved in flu immunization activities, who said uptake rates seem to be maintaining a rise seen during the 2009 H1N1 pandemic months, while raising concerns about what will happen next flu season without federal economic stimulus money to help support vaccine purchase and administration.

The 43-page vaccine plan, the first since 1994, spells out goals for improving the nation’s vaccine system by addressing research and development, supply, financing, distribution, safety, global cooperation, and decision making among consumers and healthcare providers. It incorporates input from public health and medical experts, officials from different levels of government, and the public.

It also lists 10 implementation priorities, which include items such as prioritizing domestic and global vaccine targets, strengthening the scientific base for developing and licensing new flu vaccines, and enhancing the vaccine safety system.

A series of regional stakeholder meetings scheduled for spring and summer is designed to flesh out strategies to implement the goals, the HHS said today in a press release.

Bruce Gellin, MD, MPH, who is HHS assistant secretary for health and director of its National Vaccine Program Office, said in the press release that the plan sets out a 10-year vision for more effectively preventing infectious diseases and reducing adverse vaccine reactions. “The plan is national in scope. Implementation will require a well-organized effort among stakeholders, including federal, state and local policymakers, health care providers, manufacturers, academia, philanthropic organizations, and the public,” he said in the statement.

The HHS said the strategy’s final implementation plan will be completed by the end of 2011.

During the part of the NVAC meeting that focused on this season’s flu vaccination activities, Cindy Weinbaum, MD, MPH, associate director of immunization services at the US Centers for Disease Control and Prevention (CDC), said a record 163 million doses have been distributed this season and manufacturers produced and shipped it quickly, which has smoothed the road for immunization activities.

Federal health officials are watching flu vaccine uptake closely this year to see if rates achieved during a pandemic season will carry over to a more traditional flu season and if a more simplified universal immunization recommendation will have an effect on vaccination rates.

The CDC’s internal weekly surveys so far show that rates for the seasonal flu vaccine are trending higher than last year among children. Preliminary data also show that last year’s gains are being maintained with adults, healthcare workers, and pregnant women.

Read more….

Related

Filed Under: HHS, Influenza Vaccines, United States Tagged With: increase vaccine uptake, universal flu vaccine recommendation

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Follow Us

SaneVax on FacebookSaneVax on TwitterSaneVax on LinkedInSaneVax on YoutubeSaneVax RSS Feed

Help Support SaneVax

Notice: We need your support. This massive research & presentation comes from a team of volunteers. We need your help to keep this critical information available.



SaneVax relies on support from participants like you. We are a 501 (c)(3) non-profit corporation, donations are tax deductible. Help keep this venue available and support the spirit – Thank you!

This Week’s Survivor

Freek-Netherlands

Gone After MMR and DTP: Freek, The Netherlands

Categories

Links

  • Creating an HPV Industry
  • File a VAERS Report
  • Gardasil and Unexplained Deaths
  • HPV Industry Timeline
  • HPV Mechanisms of Action in Women
  • HPV Vaccine Fact Sheet
  • Petition: Rescind HPV Vaccine Approval
  • Presentation to the FDA
  • Supreme Court Arguments

HPV Vaccine VAERS Reports

Description 12/14/2019  TOTAL
Disabled 3,092
Deaths 523
Did Not Recover 13,072
Abnormal Smear 695
Cervical Cancer 186
Infertility 52
Life-threatening 1,001
Emergency Room 15,419
Hospitalized 6,448
Extended Hosp. Stay 304
Serious 9,497
Total Adverse Events 64,270

Access expanded report here.

Related

Subscribe2


 

Log In

Featured Video

gardisil and swine flu

Gardasil & Swine Flu, Inconvenient Truth

News

SaneVax News Blog!
News

Videos

Safety • Victims • Pharma
No Genetic Epidemic

Contact

Contact S.A.N.E.Vax
S.A.N.E.VAX log thumbnail

Copyright © 2025 SaneVax, Inc. · Site by TheWebElves.com a div. of KalaRhythms.org · Log in